Article info
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
Gemcitabine-induced haemolytic uraemic syndrome in pancreatic adenocarcinoma
- Correspondence to Dr Adarsh Das, adarshdas7{at}gmail.com
Citation
Gemcitabine-induced haemolytic uraemic syndrome in pancreatic adenocarcinoma
Publication history
- Accepted March 22, 2019
- First published April 8, 2019.
Online issue publication
January 25, 2023
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.